Serum thyroglobuline at the time of remnant ablation in predicting clinical outcome in patients with low risk differentiated thyroid carcinoma

Akgun, A.Erdim, O.Yazici, B.Ozcan, Z.Ozkilic, H.2019-10-272019-10-2720061619-7070https://hdl.handle.net/11454/38381eninfo:eu-repo/semantics/closedAccessSerum thyroglobuline at the time of remnant ablation in predicting clinical outcome in patients with low risk differentiated thyroid carcinomaConference Object33S328S328WOS:000202967401188Q1